Author

Emma R.H. Gold

Mount Sinai Health SystemORCID 0009-0001-5667-8553Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Adam L. GreeniD· 1 shared Daniel Jay BratiD· 1 shared Dolores HambardzumyaniD· 1 shared Eita UchidaiD· 1 shared Gabrielle LinkiD· 1 shared Gonzalo PiñeroiD· 1 shared Guo HuiD· 1 shared Herminio Joey Cardona· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam L. GreenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical Models

Yusuke Tomita, Gabrielle Link, Yi Ge, Emma R.H. Gold, Herminio Joey Cardona, Megan M. Romero, Samantha Gadd, Jun Watanabe, Eita Uchida, Rintaro Hashizume, Yoshihiro Tanaka, Nozomu Takata, Gonzalo Piñero, Dolores Hambardzumyan, Ivan Spasojević, , Oren Josh Becher

This study evaluates combination therapy of CDK4/6 and MEK inhibitors in DMG models, finding survival benefits in GEM but not PDX models.

PLoS ONE · Dec 22, 2025Peer-reviewedCancer Biology